Skip to main content
. 2014 Sep 6;3(2):84–92.

Table 3.

Protein pathology in FTD (n=97)

Tau-positive n=30 (30.9%) No of cases

Pick 9 (9.3%)
FTLD-tau 12 (12.4%)
CBD 8 (8.2%)
PSP 1 (1.0%)

Tau-negative n=67 (69.1%)

TDP-43
    type A 8 (8.2%)*
    type B 38 (39.2%)
    type C 5 (5.2%)**
    type D 1 (1.0%)
FUS 5 (5.2%)
FTLD-nipp 10 (10.3%)

FTLD-nipp=FTLD with no identified protein pathology;

*

Including three cases with type A/B pathology;

**

Including one case that also exhibited FUS positive inclusions.